Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?

BACKGROUND: Patients positive for anti-glutamic acid decarboxylase 65 (GAD65) antibodies have attracted increasing attention. Their clinical manifestations are highly heterogeneous and can be comorbid with tumors. Currently, there is no consensus on the therapeutic regimen for anti-GAD65-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao-Ran, Zhang, Yu-Di, Wang, Qun, Shao, Xiao-Qiu, Li, Zhi-Mei, Lv, Rui-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106675/
https://www.ncbi.nlm.nih.gov/pubmed/32228575
http://dx.doi.org/10.1186/s12868-020-00561-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106675/
https://www.ncbi.nlm.nih.gov/pubmed/32228575
http://dx.doi.org/10.1186/s12868-020-00561-9

Ejemplares similares